Optical Device
Multi-Periscopic Prism (MPP) glasses for Homonymous Hemianopia
Visual Health and Surgical Center, Palm Springs, FL
Multi-Periscopic Prism (MPP) glasses +1 moreN/ARecruitingLed by Eli Peli, OD MScResearch Sponsored by Massachusetts Eye and Ear InfirmaryEligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Must not have
Timeline
Screening 3 weeks
Treatment Varies
Follow Upat 6 months
Awards & highlights
No Placebo-Only Group
Study Summary
This trial will compare two types of high-power prism glasses to help patients with half-blindness caused by damage to the same side of both eyes.
Eligible Conditions
- Homonymous Hemianopia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in detection rate for hazards approaching from the blind side in the VR walking simulator test
Secondary outcome measures
Change in detection response time for hazards approaching from the blind side in the VR walking simulator test
Continuation rate (at end of crossover)
Continuation rate (long term)
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: MPP first, FPP secondExperimental Treatment2 Interventions
Participants in this arm will receive the MPP in the first period of the crossover and the FPP in the second period.
Group II: FPP first, MPP secondExperimental Treatment2 Interventions
Participants in this arm will receive the FPP in the first period of the crossover and the MPP in the second period.
Find a site
Who is running the clinical trial?
Massachusetts Eye and Ear InfirmaryLead Sponsor
101 Previous Clinical Trials
12,419 Total Patients Enrolled
2 Trials studying Homonymous Hemianopia
50 Patients Enrolled for Homonymous Hemianopia
National Eye Institute (NEI)NIH
527 Previous Clinical Trials
1,197,929 Total Patients Enrolled
3 Trials studying Homonymous Hemianopia
123 Patients Enrolled for Homonymous Hemianopia
Eli Peli, OD MScPrincipal Investigator
Schepens Eye Research Institute of Massachusetts Eye and EarMedia Library
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there vacancies available for patients to join this clinical experiment?
"Data hosted on clinicaltrials.gov explicates that this trial is not presently recruiting patients, despite having been initially posted January 1st 2023 and last updated August 22nd 2022. However, 11 other medical studies are currently enrolling participants at the moment."
Answered by AI
What qualifications must a participant fulfill to be eligible for this clinical trial?
"This clinical trial requires 65 people with hemianopsia to participate, with ages ranging from 7-80 years. Crucially, these individuals must possess minimum visual acuity of 20/50 in each eye (corrective lenses if needed), and be able walk independently or with the aid of a cane or walking frame."
Answered by AI
Are elderly individuals eligible to be enrolled in this clinical trial?
"This clinical trial is limited to participants aged 7-80. Concurrently, there are 5 trials for minors and 10 studies that focus on patients above the age of 65."
Answered by AI
Who else is applying?
What state do they live in?
Texas
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0
Why did patients apply to this trial?
I’ve been involved in the Rothschild Hospital visual stimulation therapy in Paris. I’ve tried Peli Prisms. Had a stroke just 1 year ago. It would be great if you had some kind of outreach of your trial to Europe (UK or France).
Patient